Date of response: 8 June 2026

Outcome: Information not disclosed

Category: Medicines Optimisation

Request

Liothyronine audits (follow-up to FOI 26-1548)

ICB Response

NN ICB 26 1628 Response Letter Final

pdf (220K)

Close
Search